$NVAC
NorthView Acquisition Corp Stock $nvac

$nvac Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023017591 Filed on March 06, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$443.7K	$407.0K	$1.271M
YoY Change	83.66%	810.33%	2720.31%
Operating Profit	-$443.7K		-$1.271M
YoY Change	83.66%
Interest Expense	$1.268M	$1.319M	$8.938M
YoY Change	-67.91%	118.41%	1379.65%
% of Operating Profit
Other Income/Expense, Net	$100.0K		$0.00
YoY Change			-100.0%
Pretax Income	$824.0K	$912.3K	$7.667M
YoY Change	-77.78%	203.31%	2451.99%
Income Tax	$383.1K	$429.7K	$499.2K
% Of Pretax Income	46.49%	47.11%	6.51%
Net Earnings	$440.9K	$482.6K	$7.168M
YoY Change	-88.11%	60.44%	2285.83%
Net Earnings / Revenue
Basic Earnings Per Share	$0.02		$0.30
Diluted Earnings Per Share	$0.02	$0.02	$0.30
COMMON SHARES
Basic Shares Outstanding	24.17M shares	24.17M shares	5.194M shares
Diluted Shares Outstanding	5.194M shares		5.194M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$55.61K	$193.5K	$193.5K
YoY Change	-89.11%	-73.9%	-73.9%
Cash & Equivalents	$55.61K	$193.5K
Short-Term Investments
Other Short-Term Assets	$292.4K	$318.2K	$318.2K
YoY Change	-22.78%	-4.27%	-4.27%
Inventory
Prepaid Expenses
Receivables		$0.00	$0.00
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$348.0K	$511.7K	$511.7K
YoY Change	-61.95%	-53.42%	-53.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.39M	$194.2M	$194.2M
YoY Change	-94.59%	1.18%	1.18%
Total Long-Term Assets	$10.39M	$194.2M	$194.2M
YoY Change	-94.59%	1.18%	1.18%
TOTAL ASSETS
Total Short-Term Assets	$348.0K	$511.7K	$511.7K
Total Long-Term Assets	$10.39M	$194.2M	$194.2M
Total Assets	$10.74M	$194.7M	$194.7M
YoY Change	-94.43%	0.87%	0.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$463.0K	$448.5K	$448.5K
YoY Change	440.96%	327.53%	327.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.654M	$935.8K	$935.8K
YoY Change	3001.0%	778.55%	778.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.432M	$857.8K	$857.8K
YoY Change	-57.1%	-88.11%	-88.11%
Total Long-Term Liabilities	$1.432M	$857.8K	$857.8K
YoY Change	-57.1%	-88.11%	-88.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.654M	$935.8K	$935.8K
Total Long-Term Liabilities	$1.432M	$857.8K	$857.8K
Total Liabilities	$4.087M	$1.830M	$1.830M
YoY Change	19.39%	-75.0%	-75.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.307M	-$620.0K
YoY Change		-89.51%
Common Stock	$519.00	$519.00
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.307M	-$619.5K	$192.9M
YoY Change
Total Liabilities & Shareholders Equity	$10.74M	$194.7M	$194.7M
YoY Change	-94.43%	0.87%	0.87%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$440.9K	$482.6K	$7.168M
YoY Change	-88.11%	60.44%	2285.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$966.6K	-$179.4K	-$581.2K
YoY Change	319.63%	-72.92%	-12.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$185.7M	-$30.00	$33.45K
YoY Change		-100.0%	-100.02%
Cash From Investing Activities	$185.7M	-$30.00	$33.45K
YoY Change		-100.0%	-100.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$7.701M
YoY Change			-103.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$184.8M	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-$966.6K	-179.4K	-$581.2K
Cash From Investing Activities	$185.7M	-30.00	$33.45K
Cash From Financing Activities	-$184.8M	0.000
Net Change In Cash	-$137.9K	-179.4K	-$547.7K
YoY Change	-40.14%	-124.2%	-173.9%
FREE CASH FLOW
Cash From Operating Activities	-$966.6K	-$179.4K	-$581.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41177
CY2022	dei	Entity Registrant Name EntityRegistrantName	NORTHVIEW ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3437271
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	207 West 25th St
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	9th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2022	dei	City Area Code CityAreaCode	(212)
CY2022	dei	Local Phone Number LocalPhoneNumber	494-9022
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	NVAC
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	192307500	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24168750	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	Boston, MA
CY2022Q4	us-gaap	Cash Cash	193486	usd
CY2021Q4	us-gaap	Cash Cash	741228	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	318218	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	332396	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	25000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	511704	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1098624	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	308218	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	194224782	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	191653961	usd
CY2022Q4	us-gaap	Assets Assets	194736486	usd
CY2021Q4	us-gaap	Assets Assets	193060803	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	448480	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	104898	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	462271	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	25000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1613	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	935751	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	106511	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	36940	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	857787	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	7216022	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1830478	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7322533	usd
CY2022Q4	nvac	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	18975000	shares
CY2021Q4	nvac	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	18975000	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.2
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.1
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	193525484	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	191647500	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5193750	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5193750	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5193750	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5193750	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	519	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	519	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-619995	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5909749	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-619476	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5909230	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	194736486	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	193060803	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1270554	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	45047	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1270554	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-45047	usd
CY2022	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	2579268	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	6461	usd
	nvac	Offering Costs Allocated To Warrants OfferingCostsAllocatedToWarrants	258548	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6358235	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-597567	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	8937503	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	345480	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7666949	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	300433	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	499211	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7167738	usd
	us-gaap	Net Income Loss NetIncomeLoss	300433	usd
CY2022	nvac	Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	18975000	shares
	nvac	Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	738327	shares
CY2022	nvac	Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars	0.3
	nvac	Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars	0.06
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5193750	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4166586	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.3
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3570576	usd
	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	3997687	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	13802926	usd
	us-gaap	Net Income Loss NetIncomeLoss	300433	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5909230	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5909230	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1877984	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7167738	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-619476	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7167738	usd
	us-gaap	Net Income Loss NetIncomeLoss	300433	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2579268	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6461	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	258548	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-6358235	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-597567	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-322396	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	640614	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	343582	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	21655	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	462271	usd
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	36940	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	23387	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	1613	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-581189	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-662393	usd
	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	191647500	usd
	us-gaap	Payments To Acquire Other Receivables PaymentsToAcquireOtherReceivables	25000	usd
CY2022	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	8447	usd
CY2022	us-gaap	Proceeds From Collection Of Other Receivables ProceedsFromCollectionOfOtherReceivables	25000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33447	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-191672500	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	186300000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7347500	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-204841	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	366538	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	193076121	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-547742	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	741228	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	741228	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	193486	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	741228	usd
	nvac	Initial Classification Of Warrant Liabilities InitialClassificationOfWarrantLiabilities	7813589	usd
CY2022	nvac	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	1877984	usd
	nvac	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	13802926	usd
CY2021Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	25000	usd
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	204841	usd
	nvac	Deferred Offering Costs Included In Accrued Offering Costs And Expenses DeferredOfferingCostsIncludedInAccruedOfferingCostsAndExpenses	13243	usd
CY2021Q4	us-gaap	Stock Issued1 StockIssued1	2475000	usd
CY2021Q4	nvac	Purchase Share Of Common Stock Per Share PurchaseShareOfCommonStockPerShare	11.5
CY2021Q4	nvac	Sold Price Per Unit SoldPricePerUnit	10
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	189750000	usd
CY2022	nvac	Warrants Warrants	7347500	shares
CY2022Q4	nvac	Number Of Shares NumberOfShares	697500	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1
CY2022	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	7959726	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	3450000	usd
CY2022Q4	nvac	Shares Cost SharesCost	3570576	usd
CY2022Q4	nvac	Warrants Cost WarrantsCost	259527	usd
CY2022	nvac	Other Offering Costs OtherOfferingCosts	679623	usd
CY2022Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Arbitrage Investments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentArbitrageInvestments	0.80	pure
CY2022	nvac	Business Combination Percentage Of Post Transaction BusinessCombinationPercentageOfPostTransaction	0.50	pure
CY2021Q4	nvac	Public Offering Amount PublicOfferingAmount	191647500	usd
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.1
CY2021Q4	nvac	Operating Bank Account OperatingBankAccount	741228	usd
CY2021Q4	nvac	Maturity Days MaturityDays	P185Y
CY2021Q4	nvac	Company Obligation Percentage CompanyObligationPercentage	1	pure
CY2022	nvac	Trust Account Per Public Share TrustAccountPerPublicShare	10.2
CY2022	nvac	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022	nvac	Deposit Amount DepositAmount	1897500	usd
CY2022	nvac	Price Per Share PricePerShare	0.1
CY2022	nvac	Aggregate Amount AggregateAmount	3795000	usd
CY2022	nvac	Aggregate Price Per Share AggregatePricePerShare	0.2
CY2022	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	5000001	usd
CY2022Q4	nvac	Public Per Share PublicPerShare	10.1
CY2022Q4	nvac	Working Capital WorkingCapital	200000	usd
CY2022	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	25000	usd
CY2022	nvac	Unsecured Promissory Note UnsecuredPromissoryNote	204841	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements.</p><p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p><p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P185D
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P185D
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	194224782	usd
CY2022	nvac	Gross Unrealized Gains GrossUnrealizedGains	43626	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	194268408	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	191653961	usd
	nvac	Gross Unrealized Losses GrossUnrealizedLosses	-12912	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	191641049	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.065	pure
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17404250	shares
CY2022	nvac	Payment Of Stock Issuance Costs PaymentOfStockIssuanceCosts	7701178	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	258548	usd
CY2022	nvac	Potential Shares Of Common Stock PotentialSharesOfCommonStock	17404250	shares
CY2022	nvac	Gross Proceeds GrossProceeds	189750000	usd
CY2022	nvac	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-4204248	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-7701178	usd
CY2021Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	13802926	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	191647500	usd
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	1877984	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	193525484	usd
CY2021Q4	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the Company sold 18,975,000 Units, (which included 2,475,000 Units issued pursuant to the full exercise of the over-allotment option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share of common stock, one right, and one-half of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth (1/10) of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.5
CY2022Q4	nvac	Sale Of Stock Price Per Shares SaleOfStockPricePerShares	9.2
CY2022	nvac	Equity Proceed Ownership Percentage EquityProceedOwnershipPercentage	0.60	pure
CY2022Q4	us-gaap	Share Price SharePrice	18
CY2022	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); ●if, and only if, the last sale price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	7347500	usd
CY2021Q2	us-gaap	Sponsor Fees SponsorFees	25000	usd
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.005
CY2021Q2	nvac	Shares Of Common Stock SharesOfCommonStock	5175000	shares
CY2021Q2	nvac	Common Stock Stated Value Per Share CommonStockStatedValuePerShare	0.0001
CY2021Q4	nvac	Shares Of Common Stock SharesOfCommonStock	862500	shares
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a 1.1- for-1 stock dividend of its common stock
CY2021Q4	nvac	Shares Of Common Stock SharesOfCommonStock	4743750	shares
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	618750	shares
CY2022	nvac	Common Stock Exceeds Per Share CommonStockExceedsPerShare	12
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	150000	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2022	nvac	Additional Advanced From Sponsor AdditionalAdvancedFromSponsor	4841	usd
CY2022Q2	nvac	Promissory Note PromissoryNote	25000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1500000	usd
CY2022	nvac	Warrants Price Per Share WarrantsPricePerShare	1
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	25000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1613	usd
CY2022	nvac	Business Combination Percentage BusinessCombinationPercentage	0.0368	pure
CY2022	nvac	Gross Proceeds Amount GrossProceedsAmount	6986250	usd
CY2022Q4	nvac	Business Combination Percentage Rate BusinessCombinationPercentageRate	0.0368	pure
CY2022Q4	nvac	Cash Percentage CashPercentage	0.275	pure
CY2022Q4	nvac	Equity Percentage EquityPercentage	0.725	pure
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	3570576	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	232484	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	7678	usd
CY2022	nvac	Exercisable Per Share ExercisablePerShare	11.5
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q4	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	155000000	usd
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	155000000	pure
CY2022Q4	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	3875000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Shares Issued SharesIssued	5175000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	862500	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	450000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5193750	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5193750	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5193750	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5193750	shares
CY2022Q4	nvac	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	18975000	shares
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	36940	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	425	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	195544	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8103	usd
CY2022	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	857787	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	7216022	usd
CY2022	nvac	Aggregate Value Of Public Warrants AggregateValueOfPublicWarrants	450656	usd
	nvac	Aggregate Value Of Public Warrants AggregateValueOfPublicWarrants	3890177	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0474	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P90Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.077	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.108	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10.13	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9.07	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	232484	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8103	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	36940	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	462271	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-187441	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8103	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	224381	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8103	usd
CY2022	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	499211	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
	us-gaap	Other Operating Income OtherOperatingIncome	2023	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	224381	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	8103	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.174	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.418	pure
CY2022	nvac	Warrant Issuance Costs Percentage WarrantIssuanceCostsPercentage	0	pure
CY2021	nvac	Warrant Issuance Costs Percentage WarrantIssuanceCostsPercentage	0.181	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.029	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.027	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.065	pure
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent		usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	nvac	Offering Costs Allocated To Warrants OfferingCostsAllocatedToWarrants		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	nvac	Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	18975000	shares
	nvac	Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	738327	shares
	nvac	Basic Net Income Per Share Common Stock Subject To Possible Redemption BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption	0.06
CY2022	nvac	Basic Net Income Per Share Common Stock Subject To Possible Redemption BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption	0.30
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4166586	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments		usd
CY2022	us-gaap	Payments To Acquire Other Receivables PaymentsToAcquireOtherReceivables		usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
	us-gaap	Proceeds From Collection Of Other Receivables ProceedsFromCollectionOfOtherReceivables		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	nvac	Initial Classification Of Warrant Liabilities InitialClassificationOfWarrantLiabilities		usd
CY2022Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross		usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2022	nvac	Deferred Offering Costs Included In Accrued Offering Costs And Expenses DeferredOfferingCostsIncludedInAccruedOfferingCostsAndExpenses		usd
CY2022	nvac	Gross Unrealized Losses GrossUnrealizedLosses		usd
	nvac	Gross Unrealized Gains GrossUnrealizedGains		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001859807

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
nvac-20221231_lab.xml	Edgar Link	unprocessable
0001213900-23-017591-index-headers.html	Edgar Link	pending
0001213900-23-017591-index.html	Edgar Link	pending
0001213900-23-017591.txt	Edgar Link	pending
0001213900-23-017591-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_northviewacq.htm	Edgar Link	pending
f10k2022ex31-2_northviewacq.htm	Edgar Link	pending
f10k2022ex32-1_northviewacq.htm	Edgar Link	pending
f10k2022ex32-2_northviewacq.htm	Edgar Link	pending
f10k2022ex4-3_northviewacq.htm	Edgar Link	pending
f10k2022_northviewacq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvac-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
nvac-20221231_cal.xml	Edgar Link	unprocessable
nvac-20221231_def.xml	Edgar Link	unprocessable
nvac-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_northviewacq_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVAC
NorthView Acquisition Corp Stock $nvac

2023 Q1 Form 10-K Financial Statement

#000121390023017591 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVAC NorthView Acquisition Corp Stock $nvac

2023 Q1 Form 10-K Financial Statement

#000121390023017591 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVAC
NorthView Acquisition Corp Stock $nvac